Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
MENBS clinical interventions
Locations
1
China
Regenerative Medicine Center and Red Blood Cell Disorders Center
Tianjin, Tianjin Municipality, China
Start Date
December 1, 2024
Primary Completion Date
October 31, 2026
Completion Date
November 30, 2026
Last Updated
February 11, 2026
NCT03653338
NCT07112703
NCT06490627
NCT06734520
NCT06466304
NCT04090268
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions